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Structured abstract 
Background. Myocardial flow reserve (MFR) in the non-infarct-related area (NIRA) 
has been reported to be impaired after the onset of myocardial infarction (MI). The aim 
of this study was to determine whether microvascular dysfunction in the NIRA is related 
to left-ventricular remodeling after MI. 
Methods. We prospectively studied 17 patients who suffered their first single-vessel MI, 
and who underwent successful revascularization. The MFR in the NIRA was assessed 
quantitatively using 13N-ammonia positron emission tomography within 2 weeks after 
the onset. Peak creatinine kinase and the defect score on 99mTc-tetrofosmin myocardial 
perfusion imaging were used as an index of the severity of MI. The left-ventricular 
end-diastolic volume index (LVEDVI) was calculated using left ventriculography at 1 
month and 6 months after the onset. 
Results. Patients with severely impaired MFR (< 2.09) had higher peak creatinine 
kinase values (6,000 ± 5,485 IU/L vs. 2,250 ± 1,950 IU/L, p = 0.0081), defect scores 
(16.3 ± 5.9 vs. 7.9 ± 6.5, p = 0.0404), and LVEDVI at 1 month (125.6 ± 34.4 mL/m2 vs. 
82.8 ± 17.7 mL/m2, p = 0.0036) than those with mildly impaired MFR (≥ 2.09). 
Moreover, the differences of LVEDVI between the 2 groups persisted over 6 months 
(133.3 ± 43.6 mL/m2 vs. 89.5 ± 17.3 mL/m2, p = 0.0078). The MFR in the NIRA 
correlated inversely with the LVEDVI at 1 month and 6 months (r = -0.590, p = 0.0127 
and r = -0.729, p = 0.0031, respectively). 
Conclusions. These data indicate that microvascular impairment in the NIRA might 
have contributed to left-ventricular remodeling after MI. 
Introduction 
When the myocardium is exposed to ischemia for a long period in patients with 
acute myocardial infarction (acute MI), dysfunction of the microcirculatory system 
consisting of arterioles, capillaries, and venules can hinder the restoration of adequate 
myocardial tissue perfusion even if the infarct-related coronary artery is sufficiently 
dilated. It is well known that microvascular dysfunction in the infarcted myocardium is 
closely related to the recovery of left-ventricular function and to left-ventricular 
remodeling during the chronic phase, as well as to the complications and outcome of MI 
[1][2][3]. Consequently, it is considered clinically important to improve microvascular 
function in the infarcted myocardium, as well as to achieve angiographic reperfusion by 
percutaneous coronary intervention (PCI). 
In addition to the infarcted region, microvascular function has also been reported 
to be impaired after acute MI even in the non-infarcted myocardium, which is not 
directly supplied by the infarct-related coronary artery. Although this decrease is 
gradually resolved over time, there have been cases in which the response was not 
normalized even after 6 months [4]. Using a rat model of myocardial infarction with 
cardioselective overexpression of the angiotensin II type 1 receptor, de Boer, et al. have 
demonstrated that MI causes a decrease in microvessel density in regions of the 
non-infarcted myocardium [5]. Thus, microvascular dysfunction secondary to acute MI 
involves not only the infarcted myocardium, but also the non-infarcted myocardium. 
However, the clinical significance of microvascular dysfunction in the 
non-infarcted myocardium has not been fully examined. We hypothesized that 
microvascular dysfunction in the non-infarcted myocardium, as well as the infarcted 
myocardium, might have adverse effects on cardiac function after MI. Thus, we 
investigated, using adenosine triphosphate (ATP) -loaded 13N ammonia positron 
emission tomography (PET), the relationship between microvascular dysfunction in the 
non-infarcted myocardium and left-ventricular remodeling after MI in patients whose 
epicardial coronary arteries had been successfully revascularized. 
Materials and Methods 
Subjects and protocol 
This study included 17 consecutive patients (12 men and 5 women with a mean 
age of 66.4 ± 11.3 years; range: 48 to 89 years) who suffered acute MI and were 
successfully treated by PCI within 12 hours after the onset of symptoms, and 6 normal 
subjects (4 men and 2 women with a mean age of 62.3 ± 8.2 years; range: 48 to 74 
years) who had no clinical or echocardiographic evidence of cardiac disease. The 
inclusion criteria were as follows: 1) first acute MI, 2) single-vessel disease, and 3) 
successful recanalization by PCI (defined as < 25% residual stenosis and thrombolysis 
in myocardial infarction (TIMI) flow grade 3) within 12 hours after the onset of 
symptoms. Myocardial infarction was confirmed by the presence of chest pain for at 
least 30 min, ST segment elevation of more than 0.2 mV in at least two contiguous leads, 
and elevation of the serum creatinine kinase level to more than three times the upper 
limit of normal. We excluded patients who had another cardiac event during follow-up, 
and those who were hemodynamically unstable at the time of the PET study. 
All patients received an intravenous bolus injection of 5,000 U of heparin before 
angioplasty. Intracoronary isosorbide dinitrate (2 mg) was given before coronary 
angiography, which was performed via the femoral approach using the Judkins 
technique. After an additional intravenous or intra-arterial bolus injection of 5,000 U of 
heparin, coronary angioplasty (including rescue stenting) was performed. An 
angiographic criterion of < 25% residual stenosis was used to determine the end point of 
the angioplasty procedure. Serum creatinine kinase (CK) was measured serially every 3 
hours after recanalization, until the peak value was obtained. Patients with coronary 
stenting received antiplatelet treatment with ticlopidine and aspirin (both at 100 mg 
twice a day). Angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II 
receptor blockers (ARB) were routinely administered, if not contraindicated and if well 
tolerated. All patients underwent follow-up angiography to examine any restenosis of 
the infarct-related artery and the left-ventricular volume at 1 month and 6 months after 
the onset. The study protocol was approved by the institutional Ethical Committee, and 
all patients gave their informed consent. 
 
Analysis of coronary angiography and left ventriculography 
Coronary angiography and biplane left ventriculography were performed at the 
onset , 1 month and 6 months thereafter. Coronary stenosis (percent diameter 
stenosis; %DS) was measured by experienced cardiologists using a quantitative 
cardiovascular angiographic software program (Automated Coronary Analysis D.C.I., 
Phillips, Best, Netherlands). Significant stenosis was defined as luminal narrowing of > 
50%. Retrograde collateral vessels were graded on a four-point scale according to the 
system of Cohen and Rentrop [6]. The left-ventricular silhouette was divided into seven 
segments according to the recommendations of the American Heart Association [7]. In 
order to quantify regional LV wall motion, we used the centerline method [8]. The 
results were expressed as the standard deviation (from normal) per chord (SD/Chord) 
for each segment, and the infarct-related area (IRA) was defined as the segments 
showing hypokinesia (< -1 SD) at the onset [9], while the non-infarct-related area 
(NIRA) was defined as the remaining segments without wall motion abnormalities. In 
order to assess the extent of post-infarct left-ventricular remodeling, the left-ventricular 
end-diastolic volume index (LVEDVI) and the change in LVEDVI (ΔLVEDVI) were 
measured with the the area length method [10]. 
PET studies 
13N-ammonia PET scanning was performed using a whole-body PET scanner 
(Advance; General Electric Medical Systems, Milwaukee, WI) within 14 days after the 
onset, which allows simultaneous acquisition of 35 image slices with an inter-slice 
spacing of 4.25 mm. Patients were hemodynamically stable by the time of the PET 
study. Drugs that were considered to influence coronary microcirculation were 
withdrawn for 24 hours. A 10-min transmission scan was acquired using 68Ge /68Ga 
before the emission study for attenuation correction, followed by the administration of 
555-MBq (15-mCi) 13N-ammonia in 10 mL of saline as a slow bolus over 30 sec 
through an antecubital vein. A 5-min dynamic scan acquisition was started at the time of 
tracer administration, with frame durations of 12 × 10 s, 2 × 30 s, and 2 × 60 s. After an 
interval of 50 min from the baseline scan, intravenous infusion of ATP was started at 
0.16 mg/kg/min over 5 min, using an infusion pump to increase myocardial blood flow 
(MBF). Three minutes after the commencement of ATP infusion, the second PET scan 
was started with another 13N-ammonia injection. The PET scan protocol was identical to 
that of the baseline study. 
The MBF images at baseline and during the ATP infusion were calculated using 
the Patlak plot method [11] [12]. The regions of interest were drawn in the cavity of the 
left ventricle using a couple of slice levels to obtain a time-activity curve for the arterial 
blood which was used as the arterial input function. Time frames of 30 sec to 2.5 min 
were generally used to calculate the influx rate constants (K*) in a pixel-by-pixel 
manner based on the dynamic data. The table-lookup method was then applied to 
convert K* values into MBF. A constant recovery coefficient of 0.75 was used for the 
calculation of K* with the graphical plotting method [11] [12]. On the resulting polar 
maps, a seven-segment model was used to generate mean values for statistical analysis 
[13], in order to permit regional comparison with the corresponding 
left-ventriculography findings (Fig. 1). The MBF and myocardial flow reserve (MFR) in 
the IRA and NIRA were calculated. MFR was defined as the ratio of baseline MBF to 
MBF during ATP infusion. 
 
99mTc-tetrofosmin myocardial scintigraphy 
In order to examine the extent and severity of MI, 99mTc-tetrofosmin myocardial 
scintigraphy was performed at the same time as the PET study. We defined two nuclear 
variables using a 20-segment, 5-point scoring model [14]. Each segment was given the 
consensus score of two experienced observers using a 5-point scoring system (0 = 
normal, 1 = equivocal, 2 = moderate, 3 = severe reduction of tracer uptake, and 4 = 
absence of detectable tracer uptake). A defect score (representing the severity of MI) 
was obtained by adding the scores of the 20 segments on the tetrofosmin images, and an 
extent score (representing the extent of MI) was obtained from the total number of 
segments with abnormal tracer uptake. 
 
Statistical analysis 
Continuous variables were expressed as means ± standard deviation and analyzed 
with Student’s t-test or the Mann-Whitney U test. Categorical variables were compared 
with the chi-square test or Fisher’s exact test. The relationships between the continuous 
variables were examined by simple linear regression analysis. P values < 0.05 were 
considered statistically significant. Statistical analysis was performed with StatView Ver. 
5.0 software (SAS Institute, Cary, North Carolina). 
Results 
Baseline characteristics 
All patients had been receiving nicorandil and at least one of two drugs (ACE-I or 
ARB) that were considered to exert an effect on coronary microcirculation and 
remodeling [15][16]. The infarct-related coronary artery was the LAD in 8 patients 
(47%), LCX in 3 (18%), and RCA in 6 (35%). Myocardial blood supply was restored 
404 min (average) after infarction, indicating that reperfusion occurred relatively early 
in many patients. The mean peak CK value was 3,353 ± 3,638 IU/L. After PCI, 
reperfusion was poor in one patient, resulting in a transient slow-flow phenomenon with 
recurrence of ST-segment elevation, decrease in blood pressure, and the onset of 
ventricular arrhythmia. Eventually, PCI restored satisfactory TIMI grade 3 coronary 
flow in every patient. Stenting was performed in 13 (76%) of the 17 patients. After PCI, 
the %DS was 11.6 ± 13.5% and the minimum lumen diameter (MLD) was 2.59 ± 0.67 
mm, suggesting that the infarct-related arteries were adequately dilated. At the 
follow-up angiography 24 days after PCI, no progression of coronary stenosis was noted 
in any patient; the %DS was 14.3 ± 15.3% and MLD was 2.49 ± 0.66 mm (Tables 1 and 
2). 
 
Comparison of MBF and MFR between IRA and NIRA 
In the 17 patients, a total of 119 myocardial segments (47 infarcted and 72 
non-infarcted) were studied. 
In the IRA, the mean resting MBF was 0.62 ± 0.25 mL/min/g, and that during ATP 
infusion was 1.19 ± 0.63 mL/min/g. These two values were significantly lower than the 
corresponding values of the NIRA, which were 0.73 ± 0.26 and 1.56 ± 0.75 mL/min/g, 
respectively (p = 0.0017 and 0.0004) (Fig. 2). The mean MFR of the IRA was also 
significantly lower than that of the NIRA (1.73 ± 0.40 vs. 2.01 ± 0.53, p = 0.0006; Fig. 
3), which was lower than that of the normal subjects (2.01 ± 0.53 vs. 3.03 ± 0.63, p = 
0.027; Fig. 3). 
 
The relationship between MFR in the NIRA and the severity of infarction 
When we defined 2.09 as normal lower limit of MFR in the NIRA (the mean MFR 
minus 1.5 standard deviation of the normal subjects), the patients were divided into 2 
groups: Group-S consisted of patients with severe microvascular dysfunction in the 
NIRA (MFR < 2.09; n = 5), and Group-M consisted of patients with mild microvascular 
dysfunction in the NIRA (MFR ≥ 2.09; n = 12). The 2 groups of patients did not differ 
from each other in terms of treatment with statins and β-blockers, time of reperfusion 
after MI, frequency of left anterior descending artery disease, values of left-ventricular 
end-diastolic pressure or prevalence of risk factors (Table 3). Group-S had a 
significantly higher LVEDVI at 1 month (125.6 ± 34.4 vs. 82.8 ± 17.7 mL/m2, p = 
0.0036), ΔLVEDVI (19.6 ± 12.7 vs. -9.9 ± 7.9 mL/m2, p = 0.0003), peak CK (6,000 ± 
5,485 vs. 2,250 ± 1,950 IU/L, p = 0.0081), and defect score on tetrofosmin myocardial 
scintigraphy (16.3 ± 5.9 vs. 7.9 ± 6.5, p = 0.0404) compared with Group-M, and the 
ejection fraction of Group-S tended to be lower than that of Group-M (48.8 ± 11.9 vs. 
60.6 ± 12.8%, p = 0.099) (Table 3). 
 
The relationship between MFR in the NIRA and left-ventricular remodeling 
At the follow-up, there was a significant negative correlation between MFR in the 
NIRA and LVEDVI at 1 month (r = -0.590, p = 0.0127; Fig. 4) and 6 months (r = -0.729, 
p = 0.0031), as well as between MFR in the IRA and LVEDVI at 1 month (r = -0.627, p 
= 0.0070; Fig. 4). In addition, immediately after PCI, the two groups showed no 
difference in LVEDVI. In the Group-S patients, however, the LVEDVI at 1 month was 
significantly increased compared with that immediately after PCI (125.6 ± 34.4 ml/m2 
vs. 102.3 ± 26.4 ml/m2, p = 0.0189), and was significantly higher than in the Group-M 
patients (125.6 ± 34.4 ml/m2 vs. 82.8 ± 17.7 ml/m2, p = 0.0036). Moreover, the 
differences of LVEDVI between the 2 groups persisted over 6 months (133.3 ± 43.6 
ml/m2 vs. 89.5 ± 17.3 ml/m2, p = 0.0078; Fig. 5). 
Discussion 
All of the patients in this study attained reperfusion relatively early after the onset 
of single-vessel MI, and had excellent TIMI grade 3 coronary flow following PCI. 
About 1 month after PCI, however, the increase in LVEDVI was significantly greater in 
the Group-S patients compared with the Group-M patients. Thus, the extent of the 
decrease in the vasodilator response in the non-infarcted region was significantly related 
to the left-ventricular volume during the chronic phase. It is quite reasonable to 
speculate that the decreased vasodilator response of microvessels, not only in the 
infarcted myocardium but also in the non-infarcted myocardium, is one of the factors 
responsible for left-ventricular remodeling. In the Group-S patients, parameters that 
reflect the severity of the infarction, including the defect score on tetrofosmin 
myocardial scintigraphy and the peak CK value, were significantly increased and 
left-ventricular remodeling was advanced in the chronic phase. 
 
Microvascular dysfunction in the non-infarcted myocardium in patients with acute 
MI 
There have been several reports on the hemodynamics of the microcirculation in 
the non-infarcted myocardium of acute MI patients. Uren, et al. have performed an 
O-15 water PET study [4] and found that the coronary vasodilator response was 
decreased even in the non-infarcted myocardium, with the decrease being persistent and 
not normalized even after 6 months. According to the coronary angiography study 
conducted by Gibson, et al. [17], after the stenotic coronary artery was successfully 
dilated by PCI, the corrected TIMI frame count of the non-infarct-related coronary 
artery was comparable to that of the infarct-related artery, and the coronary blood flow 
decreased by 45% from normal. Thus, microvascular dysfunction has been reported to 
occur globally in patients with acute MI, irrespective of whether the myocardium is 
infarcted or not. These reports agree with our findings demonstrating microvascular 
damage in the remote myocardium soon after MI, a phenomenon related to the severity 
of the infarction. In our patients, the MFR of the non-infarcted myocardium was only 
2.02 on average, and lower than that determined by PET in normal subjects (3.03 on 
average), although the myocardium was normal and not supplied directly by the 
infarct-related coronary artery. In patients with diabetes, hyperlipidemia or smoking, 
microvascular function is impaired due to oxidative stress, so the blood flow reserve is 
decreased even in the absence of coronary disease [18][19][20][21]. It is possible that 
the vasodilator response was abnormal in the remote myocardium because our patients 
had had some risk factors before acute MI occurred. In the patients with lower MFR 
levels, however, myocardial infarction itself should have affected the microcirculation 
in the remote myocardium, because the peak CK and the defect score determined by 
tetrofosmin myocardial scintigraphy were significantly higher in the Group-S patients. 
Several studies have demonstrated that β-blockers have anti-remodeling effects on 
the left ventricle in patients with chronic heart failure [22]. It has been reported that 
metprolol is associated with a significant increase in coronary flow reserve (= increased 
supply) and the reduction in oxygen consumption (= decreased demand) in patients with 
coronary artery disease. This reduction in coronary vascular resistance can be explained 
by a diminution of extravascular compressive forces either due to a reduced filling 
pressure or a decrease in myocardial contractility with a reduction in vascular tone [23]. 
In our study, there were no significant differences between the 2 groups of patients in 
terms of treatment with β-blockers and the values of left-ventricular end-diastolic 
pressure after PCI. On the other hand, experimental study has shown that the effects of 
β-blocker, bisoprolol on left ventricular remodeling after MI strongly depend on infarct 
size and timing of treatment [24]. Koepfli P, et al. has reported that β-blockers 
predominantly improve coronary flow reserve in stenosis-dependent rather than remote 
segments in coronary artery disease [25]. Thus, the effects of β-blockers on remote 
myocardium after MI still remain controversial. 
 
Possible mechanism of microvascular dysfunction in the non-infarcted 
myocardium 
There are several reports explaining microvascular dysfunction in the 
non-infarcted myocardium. In a dog model of myocardial infarction (proximal 
occlusion of the left anterior descending coronary artery), focal necrosis (micro-infarcts) 
occurred in the remote myocardium [26][27]. It has been suggested that such infarction 
of the remote myocardium may occur as part of more extensive necrosis, because the 
microvascular system is shared between regions of infarcted and non-infarcted 
myocardium or as a result of vasoconstriction mediated by local neurohumoral reflexes. 
In a transgenic rat model of myocardial infarction with cardioselective overexpression 
of the angiotensin II type 1 receptor, the microvessel density decreased in the 
non-infarcted myocardium [5] independently of myocardial hypertrophy and expression 
of the vascular endothelial growth factor, suggesting that the activation of the 
renin-angiotensin system after infarction directly causes microvascular dysfunction in 
the remote myocardium. In patients undergoing PCI after acute MI, administration of an 
α-blocker (phentolamine) improved flow through non-infarct-related arteries and 
fractional shortening of non-infarcted myocardium [28]. Experimental studies have 
shown that acute coronary occlusion activates intercoronary reflexes that increase 
alpha-adrenergic activity to remote regions perfused by normal coronary arteries 
[29][30][31][32], and this phenomenon could represent an explanation for reduced MFR. 
These reports indicate that neural mechanisms might be involved in the suppression of 
microcirculatory blood flow in the remote myocardium and in left-ventricular 
dysfunction. Other studies suggest that focal myocardial damage may result in deranged 
glucose metabolism in remote myocardium [33][34]. The fact that metabolic 
abnormalities may be present in remote areas as a consequence of the greater 
compensatory contractility imposed on these regions is considered [35][36]. Such a 
phenomenon has been demonstrated in aerobic myocardium remote from the 
ischemic/necrotic area, both in experimental [37] and human models [38][39]. 
Although we could not clarify the mechanisms that caused microvascular 
dysfunction in the remote myocardium, the existence of a relationship between remote 
microvascular dysfunction and cardiac function after MI was demonstrated in this study. 
To the best of our knowledge, this is the first clinical study to demonstrate the existence 
of a relationship between microvascular dysfunction in the non-infarcted myocardium 
and the extent of left-ventricular remodeling in patients with acute MI. At present, the 
intravenous or intracoronary injection of adenosine or nicorandil [15][40][41] and the 
prevention of distal embolization using a distal protection device during PCI [42] are 
considered to lead to a better outcome through the improvement of microvascular 
dysfunction in the infarcted myocardium. Based on the present data, we speculate that a 
therapy achieving global improvement of myocardial microvascular dysfunction is 
necessary to enable better cardiac function after MI. Furthermore, the use of PET for 
non-invasive quantification of the severity of microvascular dysfunction in the infarcted 
and the non-infarcted myocardium during the subacute phase after MI should allow the 
prediction of subsequent left-ventricular function and remodeling, thus providing us 
with additional information for designing therapies. 
 
Limitations 
The results of this study should be considered in light of their limitations. First, the 
number of patients enrolled in our study was small, so a study consisting of a larger 
number of patients is needed in the future. Second, we could not clarify whether 
microvascular dysfunction in the remote myocardium after MI was a cause or a result of 
cardiac dysfunction. It has been reported that the MFR improved with time after MI, 
although it remained subnormal during the chronic phase [4][43]. In order to determine 
whether microvascular dysfunction is the cause or result, 13N-ammonia PET should be 
followed to clarify the changes in MFR over time in patients with and without 
left-ventricular remodeling. Third, we defined significant stenosis as luminal narrowing 
of >50%. Reduced coronary flow reserve in subjects with normal coronary arteries has 
been reported, and is dependent on the existence of coronary risk factors and the degree 
of endothelial dysfunction [18][19][20][21][44]. However, Gould KL, et al. has reported 
that maximal hyperemic coronary flow begins to decrease in coronary arteries with 
>50% luminal diameter stenosis [45]. 
Conclusions 
In patients with acute MI, microvascular dysfunction was noted not only in the 
infarcted myocardium but also in the non-infarcted myocardium after reperfusion. The 
extent of this dysfunction was dependent on the severity of the MI and might have 
contributed to left-ventricular remodeling after the MI. 
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  Table 1.  Baseline Characteristics of Patients (n = 17) 
     Characteristic  
 Age,y 66.4 ± 11.3 
 Male (%) 12 (71) 
 Risk factors (%)  
   Hypertension 10 (59) 
   Diabetes mellitus 6 (35) 
   Hyperlipimedia 7 (41) 
   Smoking 11 (65) 
 Medications (%)  
   Asprin 17 (100) 
   Nicorandil 17 (100) 
   ACE-I or ARB 17 (100) 
   Statins 5 (29) 
 Culprit lesions (%)  
   Left anterior descending 8 (47) 
   Left circumflex 3 (18) 
   Right coronary artery 6 (35) 
 Elapsed time, min 404 ± 281 
  Peak CK, IU/L 3353 ± 3638 
 ACE-I, angiotensine converting enzyme inhibitor;  
ARB, angiotensine II receptor blocker; CK, creatinine kinase  
  
 
  Table 2.  Cardiac catheterization findings    
  After PCI Follow up (1 month)
 Collateral flow (Rentrop grade < 1) (%) 1 (6) 17 (100) 
 TIMI flow grade (%)    
    Grade 0 0 (0) 0 (0) 
    Grade 1 0 (0) 0 (0) 
    Grade 2 0 (0) 0 (0) 
    Grade 3 17 (100) 17 (100) 
 Rescue stenting (%) 13 (76) 1 (6) 
 Residual stenosis    
   %DS, % 11.6 ± 13.5 14.3 ± 15.3 
   MLD, mm 2.59 ± 0.67 2.49 ± 0.66 
 ST re-elevation (%) 1 (6)   
 Left ventricular ejection fraction, % 46.4 ± 11.8  57.1 ± 13.4 * 
  LVEDVI, ml/m2 94.3 ± 18.8 95.4 ± 30.2 
 TIMI, thrombolysis in myocardial infarction; %DS, %diameter stenosis;  
MLD, mimal lumen diameter; LVEDVI, left ventricular end-diastolic volume index; 
*p < 0.05 vs. After PCI.  
 
 Table 3.  Comparison of clinical variables (Cut-off MFR of 2.09 in the NIRA) 
       Group S Group M  
p value 
       (MFR < 2.09) (MFR ≥ 2.09)  
 Number of patients   5 12   
 Elapsed time, min   383 ± 266 411 ± 299  0.8659 
 Culprit vessel (LAD)   3 5  0.6199 
 Diabetes mellitus   2 4  0.7933 
 Hyperlipidemia   4 3  0.1007 
 Smoking    4 4  0.1312 
 Peak CK, IU/l   6000 ± 5485 2250 ± 1950  0.0081 
 Rest MBF in IRA, l/min/g  0.499 ± 0.222 0.675 ± 0.223  0.158 
 SD/Chords in IRA at follow up, % -2.70 ± 0.98 -1.62 ± 1.23  0.1014 
 LV ejection fraction at follow up, % 48.8 ± 11.9 60.6 ± 12.8  0.099 
 LV end-diastolic pressure, mmHg  17.0 ± 9.0 14.5 ± 4.9  0.5804 
 LVEDVI at follow up, ml/m2  125.6 ± 34.4 82.8 ± 17.7  0.0036 
 ΔLVEDVI, ml/m2   19.6 ± 12.7 -9.9 ± 7.9  0.0003 
 Tc-TF extent score   7.5 ± 2.4 4.3 ± 3.1  0.0786 
 Tc-TF defect score    16.3 ± 5.9 7.9 ± 6.5  0.0404 
 NIRA, non-infarct-related area; IRA, infarct-related area; MFR, myocardial flow reserve; LAD, 
left anterior descending artery; MBF, myocardial blood flow; CK, creatinine kinase; LVEDVI, 
left ventricular end-diastolic volume index; Tc-TF, technetium-tetrofosmin 
 
 
 
 
 Figure 1.  Schematic representation of the tomographic segments. On the resulting 
polar maps, a seven-segment model was used to generate mean values for statistical 
analysis, in order to permit regional comparison with the corresponding 
left-ventriculography findings. 
 
Figure 2.  Comparison of myocardial blood flow in the IRA and NIRA. In the IRA, 
the mean resting MBF and that during ATP infusion were significantly lower than the 
corresponding values for the NIRA. 
 
 
Figure 3.  Comparison of myocardial flow reserve in the IRA and NIRA. The mean 
MFR of the IRA was also significantly lower than that of the NIRA, which was lower 
than that of the normal subjects. 
 Figure 4.  Correlation between MFR in the two areas and the follow-up LVEDVI (1 
month). There was a significant negative correlation between LVEDVI and MFR in the 
NIRA (r = -0.590, p = 0.0127), as well as between LVEDVI and MFR in the IRA (r = 
-0.627, p = 0.0070). 
 
Figure 5.  Change in LVEDVI between post-PCI and follow-up in patients with severe 
microvascular dysfunction in the NIRA (Group S; MFR < 2.09, black circles), and with 
mild microvascular dysfunction in the NIRA (Group M; MFR ≥ 2.09, white circles). In 
the Group-S patients, the LVEDVI at 1 month was significantly higher compared with 
that immediately after PCI and was significantly higher than in the Group-M patients. 
Moreover, the differences of LVEDVI between the 2 groups persisted over 6 months. 
Data were expressed as means ± standard error.  
* p = 0.0189 vs. post-PCI; ** p = 0.0326 vs. post-PCI, † p = 0.0036, †† p = 0.0078 
between the two groups. 
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